RFK Jr. Opens the Door to Six Peptides: What the New U.S. Policy Means for Research
A significant shift in American peptide policy is taking shape. On October 28, the U.S. Department of Health and Human Services (HHS), led by Secretary Robert F. Kennedy Jr., released an interim enforcement-discretion policy addressing BPC-157, TB-500, epitalon, KPV, MOTS-c and Semax. A notice published in the Federal Register on October 30 describes the policy document as a draft and invites public comment.